Arnold Lippa
Vorstandsvorsitzender bei RESPIRERX PHARMACEUTICALS INC.
Vermögen: 9 $ am 30.04.2024
Profil
Arnold S.
Lippa was the founder of Patch International, Inc. (founded in 1984) where he held the title of President & Chief Operating Officer from 1984 to 1994.
He was also the founder of DOV Pharmaceutical, Inc. (founded in 1995) where he served as a Director from 2005 to 2006.
In addition, he is the founder of Atypical BioVentures Fund, LLC (founded in 2004) where he currently holds the title of Manager.
He is also the founder of T.
Morgen Capital LLC (founded in 2005) where he currently holds the title of Senior Managing Director.
Furthermore, he is the founder of Xintria Pharmaceutical Corp.
(founded in 2006) where he currently serves as the Executive Chairman.
Lastly, he is the founder of Atypical BioCapital Management LLC (founded in 2004) where he currently holds the title of Manager.
Dr. Lippa's current job(s) include being the Executive Chairman, President & CEO at RespireRx Pharmaceuticals, Inc. since 2013 and the President of Aurora Capital LLC since 2005.
Dr. Lippa's former job(s) include being a Director-Molecular Neurobiology at Wyeth Holdings LLC, an Independent Director at Hepion Pharmaceuticals, Inc. from 2015 to 2023, and a Professor at City University of New York and New York University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.04.2023 | 7 ( 0,00% ) | 9 $ | 30.04.2024 |
Aktive Positionen von Arnold Lippa
| Unternehmen | Position | Beginn |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Vorstandsvorsitzender | 31.01.2022 |
| Xintria Pharmaceutical Corp. | Gründer | 01.01.2006 |
Aurora Capital LLC
 Aurora Capital LLC Investment Banks/BrokersFinance Aurora Capital LLC engages in providing investment banking services. It offers private placement, bridge finance, merger & acquisition, joint venture and technology transfer services. The company was founded in 1994 by Jeff Eliot Margolis and John F. McGovern and is headquartered in New York, NY. | Präsident | - |
| Atypical BioCapital Management LLC | Gründer | 01.01.2004 |
| T. Morgen Capital LLC | Gründer | 01.01.2005 |
| Atypical BioVentures Fund, LLC | Gründer | 01.01.2004 |
Ehemalige bekannte Positionen von Arnold Lippa
| Unternehmen | Position | Ende |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 22.06.2023 |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Vorstandsvorsitzender | 01.01.2006 |
Patch International, Inc.
 Patch International, Inc. Contract DrillingIndustrial Services Patch International, Inc. is engaged in the exploration and development of Crude petroleum and natural gas located in the province of Alberta. The company is headquartered in Calgary, Canada. | Gründer | 01.01.1994 |
| ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Commercial Services |
| Xintria Pharmaceutical Corp. | |
Aurora Capital LLC
Aurora Capital LLC Investment Banks/BrokersFinance Aurora Capital LLC engages in providing investment banking services. It offers private placement, bridge finance, merger & acquisition, joint venture and technology transfer services. The company was founded in 1994 by Jeff Eliot Margolis and John F. McGovern and is headquartered in New York, NY. | Finance |
| Atypical BioCapital Management LLC | |
| T. Morgen Capital LLC | |
| Atypical BioVentures Fund, LLC | |
Patch International, Inc.
Patch International, Inc. Contract DrillingIndustrial Services Patch International, Inc. is engaged in the exploration and development of Crude petroleum and natural gas located in the province of Alberta. The company is headquartered in Calgary, Canada. | Industrial Services |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
